Cimzia 200 mg (Orifarm) inj. sol. s.c. pre-filled syr. 2 x 1 ml
Active ingredient: Certolizumab Pegol
View notice details →
News topic
All current shortage notices related to Start: 2024-12, structured by product, country, active ingredient and reporting period.
14 noticesActive ingredient: Certolizumab Pegol
View notice details →Active ingredient: Bupropion Hydrochloride
View notice details →Active ingredient: Teicoplanin
View notice details →Active ingredient: Teicoplanin
View notice details →Active ingredient: Quetiapinfumarat (Ph.Eur.)
View notice details →Active ingredient: Quetiapinfumarat (Ph.Eur.)
View notice details →Active ingredient: Quetiapinfumarat (Ph.Eur.)
View notice details →Active ingredient: Quetiapinfumarat (Ph.Eur.)
View notice details →Active ingredient: Quetiapinfumarat (Ph.Eur.)
View notice details →Active ingredient: QUETIAPIN FUMARAT
View notice details →Active ingredient: QUETIAPIN FUMARAT
View notice details →Active ingredient: QUETIAPIN FUMARAT
View notice details →Active ingredient: DULOXETIN HYDROCHLORID
View notice details →Active ingredient: Methyldopa (Ph.Eur.)
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →